170 related articles for article (PubMed ID: 19144951)
21. Iatrogenic myopathies.
Mastaglia FL
Curr Opin Neurol; 2010 Oct; 23(5):445-9. PubMed ID: 20581681
[TBL] [Abstract][Full Text] [Related]
22. Impact of genetic variation in the SLCO1B1 gene on statin efficacy in low-density lipoprotein cholesterol-lowering therapy.
Couvert P; Chapman MJ; Carrié A
Pharmacogenomics; 2011 Feb; 12(2):137-9. PubMed ID: 21332305
[No Abstract] [Full Text] [Related]
23. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin-induced myopathy with concomitant use of cyclosporine: case report.
Yang WH; Zeng ZS; Ren XW; Li YP; Shang WJ; Feng GW; Zhang LR
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):772-7. PubMed ID: 22122820
[TBL] [Abstract][Full Text] [Related]
25. [Genetic marker of statin-induced rhabdomyolysis].
Chiba K; Morimoto K
Yakugaku Zasshi; 2011 Feb; 131(2):247-53. PubMed ID: 21297370
[TBL] [Abstract][Full Text] [Related]
26. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
Norata GD; Tibolla G; Catapano AL
Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
[TBL] [Abstract][Full Text] [Related]
27. Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.
Hubacek JA; Dlouha D; Adámkova V; Lanska V; Ceska R; Vrablik M
Neuro Endocrinol Lett; 2012; 33 Suppl 2():22-5. PubMed ID: 23183505
[TBL] [Abstract][Full Text] [Related]
28. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.
Santos PC; Soares RA; Nascimento RM; Machado-Coelho GL; Mill JG; Krieger JE; Pereira AC
BMC Med Genet; 2011 Oct; 12():136. PubMed ID: 21992719
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
Pasanen MK; Miettinen TA; Gylling H; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2008 Oct; 18(10):921-6. PubMed ID: 18794729
[TBL] [Abstract][Full Text] [Related]
30. Drug interactions with simvastatin.
Med Lett Drugs Ther; 2008 Oct; 50(1297):83-4. PubMed ID: 18927522
[No Abstract] [Full Text] [Related]
31. Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.
Furihata T; Satoh N; Ohishi T; Ugajin M; Kameyama Y; Morimoto K; Matsumoto S; Yamashita K; Kobayashi K; Chiba K
Pharmacogenomics J; 2009 Jun; 9(3):185-93. PubMed ID: 19238167
[TBL] [Abstract][Full Text] [Related]
32. Genetic predisposition to atorvastatin-induced myopathy: a case report.
Francesca Notarangelo M; Marziliano N; Antonietta Demola M; Pigazzani F; Guidorossi A; Angelica Merlini P; Ardissino D
J Clin Pharm Ther; 2012 Oct; 37(5):604-6. PubMed ID: 22582980
[TBL] [Abstract][Full Text] [Related]
33. [Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine].
García-Estévez DA; San Millán B; Navarro C; Sogo T
Med Clin (Barc); 2013 Jun; 140(12):565-7. PubMed ID: 23337446
[No Abstract] [Full Text] [Related]
34. ASSOCIATION OF SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1 GENE POLYMORPHISM WITH RESPONSE TO ATORVASTATIN AND ASSOCIATED MYOPATHY IN IRAQI DYSLIPIDEMIA PATIENTS.
Dheyaa Aziz N; Abbood SH; Al-Mayali AH; Hadi NR
Pol Merkur Lekarski; 2023; 51(5):496-503. PubMed ID: 38069850
[TBL] [Abstract][Full Text] [Related]
35. Role of genetic factors in statins side-effects.
Scarpini F; Cappellone R; Auteri A; Puccetti L
Cardiovasc Hematol Disord Drug Targets; 2012 Sep; 12(1):35-43. PubMed ID: 22524173
[TBL] [Abstract][Full Text] [Related]
36. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.
Feng Q; Wilke RA; Baye TM
Pharmacogenomics; 2012 Apr; 13(5):579-94. PubMed ID: 22462750
[TBL] [Abstract][Full Text] [Related]
37. [High dose of simvastatin to minimize the risk of myopathy?].
Frey O
Med Monatsschr Pharm; 2010 Sep; 33(9):354-5. PubMed ID: 21192445
[No Abstract] [Full Text] [Related]
38. GATM gene variants and statin myopathy risk.
Carr DF; Alfirevic A; Johnson R; Chinoy H; van Staa T; Pirmohamed M
Nature; 2014 Sep; 513(7518):E1. PubMed ID: 25230669
[No Abstract] [Full Text] [Related]
39. Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.
Hermann M; Bogsrud MP; Molden E; Asberg A; Mohebi BU; Ose L; Retterstøl K
Clin Pharmacol Ther; 2006 Jun; 79(6):532-9. PubMed ID: 16765141
[TBL] [Abstract][Full Text] [Related]
40. Statin induced myopathy. SEARCH genome study's results.
White C
BMJ; 2008 Dec; 337():a2792. PubMed ID: 19050021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
